Navigation Links
Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
Date:6/29/2009

SOUTHAMPTON, England, June 29 /PRNewswire/ -- Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia. The trial showed that oral VA106483 was successful in producing a predictable and sustained anti-diuretic effect in patients, as determined by increased osmolality and decreased urine output. The study also found that VA106483 was generally well tolerated among the patient population.

Nocturia (defined as waking frequently to urinate at night thereby disturbing sleep significantly) is a common condition, with prevalence increasing markedly with age. It is often the presenting symptom in men with benign prostatic hypertrophy (BPH) and affects at least 70% of BPH patients. There is currently no adequate treatment for nocturia and it represents a potential market estimated at more than US$500 million.

VA106483 is a novel small molecule drug candidate that exerts its effect directly in the kidney by binding to vasopressin (V2) receptors, which regulate water balance. It was discovered by Vantia from its extensive drug candidate library.

The double-blind, placebo-controlled, dose-response study was designed to investigate the pharmacodynamics and pharmacokinetics of single and repeated oral doses of VA106483. The trial involved 27 elderly men aged 65 years or more with a history of nocturia.

Based on these results, Vantia now plans to advance VA106483 into a larger Phase IIb clinical efficacy study in the second half of 2009.

Dr Jim Phillips, CEO of Vantia Therapeutics, said 'VA106483 was discovered and has been developed by Vantia based on its small molecule drug development expertise and is the first of several potentially high-value drug candidates in our pipeline. The c
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Vantia Therapeutics Pipeline Continues to Mature
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
4. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
5. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
6. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
7. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
8. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
9. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
10. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
11. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... A new application developed ... clinical review of specialty pharmaceuticals has increased health ... reviewed while reducing costs. ,, AIM, a leading ... health plan clients representing over 35 million consumers ... WLP ), adapted the successful clinical ...
(Date:12/16/2009)... 16 AVAX Technologies, Inc. (Pink Sheets: ... it recently closed a bridge loan financing (the ... Warrant Purchase Agreement (the "Agreement") with Firebird Global ... the Company sold a convertible promissory note, due ... of US$1,400,000, and issued a warrant to purchase ...
(Date:12/16/2009)... 16 Boston Scientific Corporation (NYSE: ... Directors has elected Nelda Connors as a Director. ... Electrical and Metal Products division of Tyco International. ... holding several positions in operations and general management. ... number of executive and management capacities with Ford, Chrysler ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Effect of Strict Diabetes Control on Heart Still Unclear 48348 1Effect of Strict Diabetes Control on Heart Still Unclear 48348 2Effect of Strict Diabetes Control on Heart Still Unclear 48348 3PHRs Protect Families From the Harshest Realities of Natural Disasters 48345 1PHRs Protect Families From the Harshest Realities of Natural Disasters 48345 2PHRs Protect Families From the Harshest Realities of Natural Disasters 48345 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2
... the 31st European Cystic Fibrosis Conference -, ... 12 /PRNewswire/,-- PTC Therapeutics, Inc. (PTC) today announced ... cystic fibrosis (CF). Results from an Israeli Phase ... treatment in adult,patients with nonsense-mutation-mediated CF demonstrated statistically,significant ...
... Data from Positive Phase 2a Trial, WALTHAM, ... ) today announced that based on feedback from ... initiate a Phase 2b clinical,trial of RG2417, an ... later this year. This will be a multi-center, ...
Other Medicine Technology:PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 2PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 3PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 4PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 5Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 3Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 4Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 5
(Date:12/17/2009)... new marketing techniques, life coaching company puts free i-phone ... worldwide!, http://itunes.apple.com/us/app/attainment-life-management/id345691804?mt=8 . For the Free download. , ... ... 2009 -- Utah based Attainment Life Management & Coaching ... want everything in life simplified into one little hand ...
(Date:12/16/2009)... Texas, Dec. 16 Austin,s Custom Tops ... countertops, co-sponsored, with Ryan Gray and Hill Country Home ... West on Wednesday, December 9th. Fifty people showed up ... their way through platefuls of sliders in support of ... What started as a casual bet over who could ...
(Date:12/16/2009)... -- Every year in the United States, 160,000 cases ... of the disease, making it the second leading cause ... , As researchers and clinicians fervently look for causes ... of studies producing more and more promising results ... genetics at Case Western Reserve University School of Medicine ...
(Date:12/16/2009)... 16 Allscripts (Nasdaq: MDRX ) ... results for the three and six months ended ... on Monday, January 11, 2010. Allscripts management will ... the company,s earnings and other information at 8:30 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal ...
(Date:12/16/2009)... Dec. 16 HealthSciences Institute will ... care professionals, teams and organizations who serve ... chronic diseases in employer, health plan, medical ... collaborative will offer free, noncommercial webinars on ... disease prevention, management and care improvement. Each ...
Breaking Medicine News(10 mins):Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2Health News:Austin-Based Business Co-Sponsors Gastric Feat for Charity 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3
... environmental information provider offers real estate community ... properties for harmful vapor intrusion, MILFORD, Conn., ... leading U.S. provider of environmental risk information,services and ... indicating a,high level of awareness of the health, ...
... and Health Care ... Service Offerings, BETHESDA, ... entered into a definitive agreement to acquire,Atlanta, Georgia based Eagle Group ... to the,U.S. Department of Defense., As part of the agreement, ...
... overweight as they conceive, raising complication risks, study finds, , , ... starting their pregnancies with type 1 or type 2 diabetes ... stayed the same, new research finds. , In some age ... found that the number of teenagers who had diabetes before ...
... who attend day care or play groups have about ... type of childhood leukaemia than those who do not, ... link. , The new research, to be presented ... Prevention of Childhood Leukaemia Conference in London, is the ...
... President and Chief,Analyst Terence Pitre, Ph.D. Pitre Equity ... based in Minneapolis, Minnesota. Dr. Pitre,said that because ... academia, truth,independence and objectivity will always form the ... is to incorporate,fundamentally sound financial analysis that also ...
... Adaptis, a leading provider of,Business Process ... it is sponsoring and exhibiting at two ... for small to mid-sized,health plans nationwide, Adaptis ... providing health plans with high-impact strategies for,improving ...
Other Medicine News:Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 2Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 3Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 2Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 3Health News:Pre-Pregnancy Diabetes Rates Have Doubled 2Health News:Pre-Pregnancy Diabetes Rates Have Doubled 3Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3Health News:New Independent Research Firm Targets Firms with Little or No Analyst Following 2Health News:Adaptis Sponsors Two Upcoming Healthcare Conferences 2
... BioTears Oral GelCaps, the patented next-generation ... is designed to systemically address the root ... syndrome. It is suggested in peer-reviewed literature ... of lubricants in other affected parts of ...
... portal to QC information, providing laboratory personnel ... access their quality control data and other ... enables Bio-Rad customers to access on-demand (InstantQC) ... as convenient online data entry and management. ...
... The OmniPod: a small, lightweight self-adhesive insulin ... directly on your body for up to three ... personalized doses of insulin into your body through ... on instructions that you program into its wireless ...
Inquire...
Medicine Products: